Sibilano R, Frossi B, Calvaruso M, Danelli L, Betto E, Dall'Agnese A, Tripodo C, Colombo MP, Pucillo CE, Gri G

The aryl hydrocarbon receptor modulates acute and late mast cell responses.

J Immunol 2012; 120-7. doi: 10.4049/jimmunol.1200009

Suram A, Kaplunov J, Patel PL, Ruan H, Cerutti A, Boccardi V, Fumagalli M, Di Micco R, Mirani N, Gurung RL, Hande MP, d'Adda di Fagagna F, Herbig U

Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions.

EMBO J 2012; 2839-51. doi: 10.1038/emboj.2012.132

Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravegna G, Bencardino K, Cercek A, Chen CT, Veronese S, Zanon C, Sartore-Bianchi A, Gambacorta M, Gallicchio M, Vakiani E, Boscaro V, Medico E, Weiser M, Siena S, Di Nicolantonio F, Solit D, Bardelli A

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.

Nature 2012; 532-6. doi: 10.1038/nature11156

Magagnotti C, Bachi A, Zerbini G, Fattore E, Fermo I, Riba M, Previtali SC, Ferrari M, Andolfo A, Benedetti S

Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers.

Biochim Biophys Acta 2012; 970-9. doi: 10.1016/j.bbadis.2012.01.014

Fanucchi F, Alpi E, Olivieri S, Cannistraci CV, Bachi A, Alpi A, Alessio M

Acclimation increases freezing stress response of Arabidopsis thaliana at proteome level.

Biochim Biophys Acta 2012; 813-25. doi: 10.1016/j.bbapap.2012.03.015

Parma G, Mancari R, Del Conte G, Scambia G, Gadducci A, Hess D, Katsaros D, Sessa C, Rinaldi A, Bertoni F, Vitali A, Catapano CV, Marsoni S, van de Velde H, Colombo N

An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens.

Int J Gynecol Cancer 2012; 792-800. doi: 10.1097/IGC.0b013e318251051a

Zhao Z, Oh S, Li D, Ni D, Pirooz SD, Lee JH, Yang S, Lee JY, Ghozalli I, Costanzo V, Stark JM, Liang C

A dual role for UVRAG in maintaining chromosomal stability independent of autophagy.

Dev Cell 2012; 1001-16. doi: 10.1016/j.devcel.2011.12.027

Grassi L, Grilli J, Lagomarsino MC

Large-scale dynamics of horizontal transfers.

Mob Genet Elements 2012; 163-167. doi: 10.4161/mge.21112

Migliardi G, Sassi F, Torti D, Galimi F, Zanella ER, Buscarino M, Ribero D, Muratore A, Massucco P, Pisacane A, Risio M, Capussotti L, Marsoni S, Di Nicolantonio F, Bardelli A, Comoglio PM, Trusolino L, Bertotti A

Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas.

Clin Cancer Res 2012; 2515-25. doi: 10.1158/1078-0432.CCR-11-2683

Schaeffer C, Cattaneo A, Trudu M, Santambrogio S, Bernascone I, Giachino D, Caridi G, Campo A, Murtas C, Benoni S, Izzi C, De Marchi M, Amoroso A, Ghiggeri GM, Scolari F, Bachi A, Rampoldi L

Urinary secretion and extracellular aggregation of mutant uromodulin isoforms.

Kidney Int 2012; 769-78. doi: 10.1038/ki.2011.456

Bonnal RJ, Aerts J, Githinji G, Goto N, MacLean D, Miller CA, Mishima H, Pagani M, Ramirez-Gonzalez R, Smant G, Strozzi F, Syme R, Vos R, Wennblom TJ, Woodcroft BJ, Katayama T, Prins P

Biogem: an effective tool-based approach for scaling up open source software development in bioinformatics.

Bioinformatics 2012; 1035-7. doi: 10.1093/bioinformatics/bts080

Olmos D, A'hern RP, Marsoni S, Morales R, Gomez-Roca C, Verweij J, Voest EE, Schöffski P, Ang JE, Penel N, Schellens JH, Del Conte G, Brunetto AT, Evans TR, Wilson R, Gallerani E, Plummer R, Tabernero J, Soria JC, Kaye SB

Patient selection for oncology phase I trials: a multi-institutional study of prognostic factors.

J Clin Oncol 2012; 996-1004. doi: 10.1200/JCO.2010.34.5074

Fumagalli M, Rossiello F, Clerici M, Barozzi S, Cittaro D, Kaplunov JM, Bucci G, Dobreva M, Matti V, Beausejour CM, Herbig U, Longhese MP, d'Adda di Fagagna F

Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation.

Nat Cell Biol 2012; 355-65. doi: 10.1038/ncb2466

Schiraldi M, Raucci A, Muñoz LM, Livoti E, Celona B, Venereau E, Apuzzo T, De Marchis F, Pedotti M, Bachi A, Thelen M, Varani L, Mellado M, Proudfoot A, Bianchi ME, Uguccioni M

HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4.

J Exp Med 2012; 551-63. doi: 10.1084/jem.20111739

Hayashi MT, Cesare AJ, Fitzpatrick JA, Lazzerini-Denchi E, Karlseder J

A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest.

Nat Struct Mol Biol 2012; 387-94. doi: 10.1038/nsmb.2245

Ray Chaudhuri A, Hashimoto Y, Herrador R, Neelsen KJ, Fachinetti D, Bermejo R, Cocito A, Costanzo V, Lopes M

Topoisomerase I poisoning results in PARP-mediated replication fork reversal.

Nat Struct Mol Biol 2012; 417-23. doi: 10.1038/nsmb.2258

Vilotti S, Biagioli M, Foti R, Dal Ferro M, Lavina ZS, Collavin L, Del Sal G, Zucchelli S, Gustincich S

The PML nuclear bodies-associated protein TTRAP regulates ribosome biogenesis in nucleolar cavities upon proteasome inhibition.

Cell Death Differ 2012; 488-500. doi: 10.1038/cdd.2011.118

Grassi L, Caselle M, Lercher MJ, Lagomarsino MC

Horizontal gene transfers as metagenomic gene duplications.

Mol Biosyst 2012; 790-5. doi: 10.1039/c2mb05330f

Zhang B, Kracker S, Yasuda T, Casola S, Vanneman M, Hömig-Hölzel C, Wang Z, Derudder E, Li S, Chakraborty T, Cotter SE, Koyama S, Currie T, Freeman GJ, Kutok JL, Rodig SJ, Dranoff G, Rajewsky K

Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model.

Cell 2012; 739-51. doi: 10.1016/j.cell.2011.12.031

Bottos A, Martini M, Di Nicolantonio F, Comunanza V, Maione F, Minassi A, Appendino G, Bussolino F, Bardelli A

Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia.

Proc Natl Acad Sci U S A 2012; E353-9. doi: 10.1073/pnas.1105026109

Yang J, Staples O, Thomas LW, Briston T, Robson M, Poon E, Simões ML, El-Emir E, Buffa FM, Ahmed A, Annear NP, Shukla D, Pedley BR, Maxwell PH, Harris AL, Ashcroft M

Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression.

J Clin Invest 2012; 600-11. doi: 10.1172/JCI58780

Prahallad A, Sun C, Huang S, Di Nicolantonio F, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A, Bernards R

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Nature 2012; 100-3. doi: 10.1038/nature10868

Lazzaro F, Novarina D, Amara F, Watt DL, Stone JE, Costanzo V, Burgers PM, Kunkel TA, Plevani P, Muzi-Falconi M

RNase H and postreplication repair protect cells from ribonucleotides incorporated in DNA.

Mol Cell 2012; 99-110. doi: 10.1016/j.molcel.2011.12.019

Lazzari C, Spreafico A, Bachi A, Roder H, Floriani I, Garavaglia D, Cattaneo A, Grigorieva J, Viganò MG, Sorlini C, Ghio D, Tsypin M, Bulotta A, Bergamaschi L, Gregorc V

Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors.

J Thorac Oncol 2012; 40-8. doi: 10.1097/JTO.0b013e3182307f17

Cicuta GM, Onofri E, Lagomarsino MC, Cicuta P

Patterns of synchronization in the hydrodynamic coupling of active colloids.

Phys Rev E Stat Nonlin Soft Matter Phys 2012; 016203. doi: 10.1103/PhysRevE.85.016203

Grilli J, Bassetti B, Maslov S, Cosentino Lagomarsino M

Joint scaling laws in functional and evolutionary categories in prokaryotic genomes.

Nucleic Acids Res 2012; 530-40. doi: 10.1093/nar/gkr711

Fassina A, Cappellesso R, Guzzardo V, Dalla Via L, Piccolo S, Ventura L, Fassan M

Epithelial-mesenchymal transition in malignant mesothelioma.

Mod Pathol 2012; 86-99. doi: 10.1038/modpathol.2011.144

Wallin JJ, Guan J, Edgar KA, Zhou W, Francis R, Torres AC, Haverty PM, Eastham-Anderson J, Arena S, Bardelli A, Griffin S, Goodall JE, Grimshaw KM, Hoeflich KP, Torrance C, Belvin M, Friedman LS

Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes.

PLoS One 2012; e36402. doi: 10.1371/journal.pone.0036402

Schaeffer C, Cattaneo A, Trudu M, Santambrogio S, Bernascone I, Giachino D, Caridi G, Campo A, Murtas C, Benoni S, Izzi C, De Marchi M, Amoroso A, Ghiggeri GM, Scolari F, Bachi A, Rampoldi L

[Mutant uromodulin is secreted in the urine of patients with familial hyperuricemic nephropathy and induces the formation of extracellular aggregates].

G Ital Nefrol 2012; 137-41.

Jones DT, Lechertier T, Mitter R, Herbert JM, Bicknell R, Jones JL, Li JL, Buffa F, Harris AL, Hodivala-Dilke K

Gene expression analysis in human breast cancer associated blood vessels.

PLoS One 2012; e44294. doi: 10.1371/journal.pone.0044294

Bianco A, Reghellin V, Donnici L, Fenu S, Alvarez R, Baruffa C, Peri F, Pagani M, Abrignani S, Neddermann P, De Francesco R

Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity.

PLoS Pathog 2012; e1002576. doi: 10.1371/journal.ppat.1002576

%PLACEHOLDER%